UK markets open in 17 minutes
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,443.29 -135.01 (-0.73%) CRUDE OIL
78.55 +0.07 (+0.09%) GOLD FUTURES
2,328.00 -3.20 (-0.14%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,718.64 -580.09 (-1.13%)
MorphoSys AG (MOR2.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:05AM CEST. Market open.
| Previous close | 16.20 |
| Open | 16.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.30 - 16.30 |
| 52-week range | 3.56 - 17.40 |
| Volume | |
| Avg. volume | 47 |
| Market cap | 2.539B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.38 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.07 |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.